BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1753683)

  • 1. The endothelial L-arginine/nitric oxide pathway and the renal circulation.
    Lüscher TF; Bock HA
    Klin Wochenschr; 1991 Sep; 69(13):603-9. PubMed ID: 1753683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nitric oxide in hypertension and renal disease progression.
    Klahr S
    Nephrol Dial Transplant; 2001; 16 Suppl 1():60-2. PubMed ID: 11369823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nitric oxide: the endogenous nitrate in the cardiovascular system].
    Tschudi MR; Lüscher TF
    Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endothelium-derived nitric oxide on renal hemodynamics and function in the sheep fetus.
    Bogaert GA; Kogan BA; Mevorach RA
    Pediatr Res; 1993 Dec; 34(6):755-61. PubMed ID: 8108188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system.
    Lüscher TF
    Eur Heart J; 1991 Nov; 12 Suppl E():2-11. PubMed ID: 1790780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide in essential and renal hypertension.
    MacAllister R; Vallance P
    J Am Soc Nephrol; 1994 Oct; 5(4):1057-65. PubMed ID: 7531511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient production of nitric oxide induces volume-dependent hypertension.
    Lahera V; Salazar J; Salom MG; Romero JC
    J Hypertens Suppl; 1992 Dec; 10(7):S173-7. PubMed ID: 1291651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.
    Tolins JP; Palmer RM; Moncada S; Raij L
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H655-62. PubMed ID: 2156453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum.
    Gur S; Kadowitz PJ; Trost L; Hellstrom WJ
    J Urol; 2007 Oct; 178(4 Pt 1):1543-8. PubMed ID: 17707054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.
    Higashi Y
    Int J Urol; 2017 Jun; 24(6):412-424. PubMed ID: 28332240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular nitric oxide: Beyond eNOS.
    Zhao Y; Vanhoutte PM; Leung SW
    J Pharmacol Sci; 2015 Oct; 129(2):83-94. PubMed ID: 26499181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
    Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
    Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin.
    Lahera V; Salom MG; Fiksen-Olsen MJ; Romero JC
    Am J Hypertens; 1991 Mar; 4(3 Pt 1):260-2. PubMed ID: 2043304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The L-arginine-NO pathway and cyclic GMP in the vessel wall.
    Stoclet JC
    Z Kardiol; 1991; 80 Suppl 7():87-90. PubMed ID: 1665267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide in the kidney.
    Ito S
    Curr Opin Nephrol Hypertens; 1995 Jan; 4(1):23-30. PubMed ID: 7743154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of endothelial function of the renal vasculature in human subjects.
    Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function in hypertension.
    Mattei P; Virdis A; Ghiadoni L; Taddei S; Salvetti A
    J Nephrol; 1997; 10(4):192-7. PubMed ID: 9377726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.